Gottlieb Targets More Efficient Clinical Trials

Drug Industry Daily
A A
FDA commissioner Scott Gottlieb highlighted the agency’s efforts to improve clinical trials during a keynote address Monday at the RAPS’ 2017 Regulatory Conference.

To View This Article:

Login

Subscribe To Drug Industry Daily